Home ›
Organizations ›
TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION
TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION
CA · Medical Research · EIN 473108868
1
Executives Disclosed
$542K
Annual Revenue
$407K
Total Assets
TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION has 1 executive with disclosed compensation. The highest-paid executive, Amber Black (Secretary), received peak total compensation of $67,838. The sector average for Medical Research executives is $311K.
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Amber Black | Secretary | $68K | $0 | 2024–2024 | 0.9x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2024 | 1 | $0 | $0 | $0 |
Email Alerts
Get notified about TREATMENTS FOR EPILEPSY AND SYMPTOMS OF SLC13A5 FOUNDATION
Get an email when a new IRS Form 990 filing is posted that includes this organization. We send a confirmation link first - we don't add you to any other list.